EquitiesIndia.com

Educational content only. EquitiesIndia.com is not a SEBI-registered Research Analyst or Investment Adviser. Nothing on this site is investment advice or a solicitation to transact in any security. All content and data is historical and for learning purposes only. Full disclaimer →

Healthcare · Health Information Services

Indegene Ltd.

INDGN

Financials as of(≥90-day lag, SEBI compliant)

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

NSE: INDGNOfficial website ↗

Key metrics

Market Cap

₹11,782 cr

P/E Ratio

26.88x

P/B Ratio

4.5x

ROE

15.55%

ROCE

20.66%

Debt / Equity

0.04x

Net Margin

14.32%

Dividend Yield

41%

EPS

₹17.02

Period

FY2025

Shareholding pattern

As of Latest
Promoter: 57.17%FII: 22.34%Public: 20.49%

Deep-dive pages

10-Year Financials→Shareholding Pattern→Dividends & Corporate Actions→
Educational content — not investment adviceThis page presents publicly available information about Indegene Ltd. for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing here constitutes investment advice, a recommendation to buy or sell any security, or a solicitation to transact. All financial data shown is sourced from public BSE/NSE filings and is at least 90 days old. Past performance is not indicative of future results. Please consult a SEBI-registered adviser before making any investment decision.